| Correspondence |
|
|
|
|
| Non-specific anti-viral approach towards Ebola virus infection: a comment on "Against Ebola: type I interferon guard risk and mesenchymal stromal cell combat sepsis" |
| Beuy Joob, Viroj Wiwanitkit |
| Sanitation 1 Medical Academic Center, Bangkok 10160, Thailand; Hainan Medical University, Haikou 571199, China; Dr. D.Y. Patil Medical University, Pune 411018, India |
|
|
|
Abstract The recent "Viewpoint" by Zhang et al. (2015) entitled "Against Ebola: type I interferon guard risk and mesenchymal stromal cell combat sepsis", pub-lished in Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), is very interesting, which mentioned the possible role of non-specific anti-viral approach towards Ebola virus infection. They noted the role of interferon and "applying a non-specific anti-viral approach during the incubation period of virus infection as an essential protection to put the host's immune system into an alert state and henceforth to slow down the viral replication." In previous report, Zhang and Wang (2014) mentioned the long history of Ebola virus infection discovery. However, the success in disease management is still not reached. Indeed, the role of interferon in treatment of Ebola has been widely discussed (Shuchman, 2014). The effectiveness of interferon has been proved in some animal models (Smith et al., 2013).
|
|
Received: 05 July 2014
Published: 05 March 2015
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
